Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse

Proteomics

Volumn 9, Issue 15, 2009, Pages 3824-3832

  Kyung, Hyun Yoo ^a   Yo, Na Kim ^b   Min, Joo Lee ^a   Je, Kyung Seong ^b   Jong, Hoon Park ^a  

^a Sookmyung Women's University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

ApolipoproteinA1; Autosomal dominant polycystic kidney disease; Inflammation; Mxi1; Renal fibrosis

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PROTEIN MXI1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; KIDNEY POLYCYSTIC DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

ANIMALS; APOLIPOPROTEIN A-I; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; POLYCYSTIC KIDNEY DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTEOME; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 68549091058     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800753     Document Type: Article

References (39)

1. Ong, A. C., Harris, P. C., Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int. 2005, 67, 1234-1247.
2. Al-Bhalal, L., Akhtar, M., Molecular basis of autosomal dominant polycystic kidney disease. Adv. Anat. Pathol. 2005, 12, 126-133.
3. Li, X., Magenheimer, B. S., Xia, S., Johnson, T. et al., A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat. Med. 2008, 14, 863-868.
4. Trudel, M., D'Agati, V., Costantini, F ., C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int. 1991, 39, 665-671.
5. Saadi-Kheddouci, S., Berrebi, D., Romagnolo, B., Cluzeaud, F. et al., Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 2001, 20, 5972-5981.
6. Stöcklin, E., Botteri, F., Groner, B ., An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J. Cell Biol. 1993, 122, 199-208.
7. Li, K. J., Shiau, A. L., Chiou, Y. Y., Yo, Y. T., Wu, C. L ., Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease. Kidney Int. 2005, 67, 710-722.
8. Qian, C. N., Knol, J., Igarashi, P., Lin, F. et al., Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J. Biol. Chem. 2005, 280, 3938-3945.
9. Veis, D. J., Sorenson, C. M., Shutter, J. R., Korsmeyer, S. J ., Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75, 229-240.
10. Kawamata, N., Sugimoto, K. J., Sakajiri, S., Oshimi, K., Koeffler, H. P., Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow. Int. J. Oncol. 2005, 26, 1369-1375.
11. Schreiber-Agus, N., Depinho, R. A., Repression by the Mad(Mxi1)-Sin3 complex. Bioessays 1998, 20, 808-818.
12. Henriksson, M., Luscher, B., Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 1996, 68, 109-182.
13. Prochownik, E. V., Eagle Grove, L., Deubler, D., Zhu, X. L. et al., Commonly occurring loss and mutation of the MXI1 gene in prostate cancer. Genes Chromosomes Cancer 1998, 22, 295-304.
14. Wang, D. Y., Xiang, Y. Y., Li, X. J., Hashimoto, M. et al., Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines. Pathol. Int. 2000, 50, 373-383.
15. Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., jr. et al., Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 1998, 4, 483-487.
16. Yoo, K. H., Sung, Y. H., Yang, M. H., Jeon, J. O. et al., Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney. Biochem. Biophys. Res. Commun. 2007, 356, 85-90.
17. Schlitt, A., Blankenberg, S., Bickel, C., Meyer, J. et al., Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease. Int. J. Cardiol. 2005, 102, 77-85.
18. Van Lenten, B. J., Wagner, A. C., Navab, M., Anantharamaiah, G. M. et al., D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 2004, 110, 3252-3258.
19. Holley, J. E., Newcombe, J., Winyard, P. G., Gutowski, N. J ., Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes. Mult. Scler. 2007, 13, 955-961.
20. Engstad, T., Viitanen, M., Arnesen, E., Predictors of death among long-term stroke survivors. Stroke 2003, 34, 2876-2880.
21. Ascaso, J. F., Fernanadez-Cru, A., Gonazlez Santos, P., Hernande, Z. et al., Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum. Am. J. Cardiovasc. Drugs 2004, 4, 299-314.
22. Heng, C. k., Low, P. S., Saha, N., Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr. Res. 2001, 49, 514-518.
23. Valkova, N., Yunis, R., Mak, S. K., Kang, K., K. ultz, D., Nek8 mutation causes overexpression of galectin-1, sorcin, and vimentin and accumulation of themajor urinary protein in renal cysts of jck mice. Mol. Cell Proteomics 2005, 4, 1009-1018.
24. Han, C. L., Chien, C. W., Chen, W. C., Chen, Y. R. et al., A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease. Mol. Cell Proteomics 2008, 7, 1983-1997.
25. Xianyin, L., Robert, L. B., Bonnie, L. B., David, H. et al., Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin. Appl. 2008, 2, 1140-1152.
26. Horiuchi, K., Umetani, M., Minami, T., Okayama, H. et al., Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA. Proc. Natl. Acad. Sci. USA 2006, 103, 17278-17283.
27. Rossé, C., Hatzoglou, A., Parrini, M. C., White, M. A. et al., RalB mobilizes the exocyst to drive cell migration. Mol. Cell Biol 2006, 26, 727-734.
28. Chien, Y., Kim, S., Bumeister, R., Loo, Y. M. et al., RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006, 127, 157-170.
29. Frank, P., Marcel, Y., Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 2000, 41, 853-872.
30. Gregorini, G., Izzi, C., Obici, L., Tardanico, R. et al., Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J. Am. Soc. Nephrol. 2005, 16, 3680-3686.
31. Trevisan, R., Dodesini, A. R., Lepore, G ., Lipids and renal disease. J. Am. Soc. Nephrol. 2006, 17, S145-S147.
32. Ramharack, R., Barkalow, D., Spahr, M. A ., Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 984-990.
33. Wang, W., Koka, V., Lan, H. Y., Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005, 10, 48-56.
34. Li, J. H., Zhu, H. J., Huang, X. R., Lai, K. N. et al., Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J. Am. Soc. Nephrol. 2002, 13, 1464-1472.
35. Biernacka,A., Zoch-Zwierz, W. M., Wasilewska, A., Porowski, T. et al., Urinary TGF-beta1 excretion in children with renal cysts. Przegl. Lek. 2006, 3, 94-96.
36. Pajkrt, D., Doran, J. E., Koster, F., Lerch, P. G. et al., Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 1996, 184, 1601-1608.
37. Skretting, G., Gjernes, E., Prydz, H., Regulation of lecithin: cholesterol acyltransferase by TGF-beta and interleukin-6. Biochim. Biophys. Acta 1995, 1255, 267-272.
38. Furlaneto, C. J., Campa, A ., A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 2000, 268, 405-408.
39. Hannigan, M., Zhan, L., Ai, Y., Huang, C. K., The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem. Biophys. Res. Commun. 1998, 246, 55-58.